Skip to Content
Merck
CN
  • Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.

Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.

Bioorganic & medicinal chemistry letters (2011-08-26)
Son T Nguyen, Xiaoyuan Ding, Michelle M Butler, Tommy F Tashjian, Norton P Peet, Terry L Bowlin
ABSTRACT

Decarboxylated ciprofloxacin (3) has been reported in the literature to have antibacterial activities against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Bacillus subtilis, Enterobacter cloacae, Serratia marcescens and especially potent activity against Escherichia coli. Herein, we report our syntheses of 3 and five additional decarboxylated fluoroquinolones (FQs). We have re-evaluated the antibacterial activity of these FQs. In contrast to previously reported data, none of these decarboxylated fluoroquinolones showed significant antibacterial activity in our assays using both the broth dilution and agar methods. Our study confirmed that the presence of a carboxylic acid group at the 3-position of the fluoroquinolone scaffold is essential for antibacterial activity.

MATERIALS
Product Number
Brand
Product Description

Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Supelco
Norfloxacin, VETRANAL®, analytical standard